Advanced search
Publication Cover
Leukemia & Lymphoma Volume 55, 2014 - Issue 8
Submit an article Journal homepage
288
Views
11
CrossRef citations to date
0
Altmetric
Letter

Up-regulation of RUNX2 in acute myeloid leukemia in a patient with an inherent RUNX2 haploinsufficiency and cleidocranial dysplasia

Dominik SchnerchDepartment of Hematology, Oncology and Stem Cell Transplantation
,
Ekkehart LauschDepartment of Pediatrics, University Medical Center, Freiburg, Germany
,
Heiko BeckerDepartment of Hematology, Oncology and Stem Cell Transplantation
,
Julia FelthausDepartment of Hematology, Oncology and Stem Cell Transplantation
,
Dietmar PfeiferDepartment of Hematology, Oncology and Stem Cell Transplantation
,
Stefan MundlosInstitute of Medical Genetics and Human Genetics, Charité University Medical Center, Berlin, Germany
,
Monika EngelhardtDepartment of Hematology, Oncology and Stem Cell Transplantation
,
Michael SchwabeDepartment of Hematology, Oncology and Stem Cell Transplantation
&
Ralph WäschDepartment of Hematology, Oncology and Stem Cell TransplantationCorrespondence[email protected]
 show all
Pages 1930-1932 | Received 14 Sep 2013, Accepted 03 Oct 2013, Published online: 24 Feb 2014

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Michele Callea, Fabiana Fattori, Enrico Silvio Bertini, Francisco Cammarata-Scalisi, Francesco Callea & Emanuele Bellacchio. (2017) Blood malignancies presenting with mutations at equivalent residues in RUNX1–2 suggest a common leukemogenic pathway. Leukemia & Lymphoma 58:8, pages 2002-2004.
Read now
Michele Callea, Emanuele Bellacchio, Fabiana Fattori, Enrico Bertini, Francesco Callea & Francisco Cammarata-Scalisi. (2016) Acute myeloid leukemia in a 3 years old child with cleidocranial dysplasia. Leukemia & Lymphoma 57:9, pages 2189-2191.
Read now

Articles from other publishers (9)

Ping Wang, Jiajia Zhang, Hui Zhang & Fang Zhang. (2022) The role of MACF1 on acute myeloid leukemia cell proliferation is involved in Runx2-targeted PI3K/Akt signaling. Molecular and Cellular Biochemistry 478:3, pages 433-441.
Crossref
Andrew M. Cobb, Syabira YusoffRobert HaywardSadia AhmadMengxi SunAnja Verhulst, Patrick C. D’HaeseCatherine M. Shanahan. (2021) Runx2 (Runt-Related Transcription Factor 2) Links the DNA Damage Response to Osteogenic Reprogramming and Apoptosis of Vascular Smooth Muscle Cells. Arteriosclerosis, Thrombosis, and Vascular Biology 41:4, pages 1339-1357.
Crossref
Liyuan Yang, Genqi Lu, Wenjing Shen, Wenjing Chen, Haiyan Lu, Guozhong Zhang, Shuo Yuan, Shushen Zheng & Jiabao Ren. (2021) Whole-exome sequencing of a novel initiation codon mutation in RUNX2 in a Chinese family with cleidocranial dysplasia. Medicine 100:45, pages e27746.
Crossref
Francisco Cammarata-Scalisi, Katia Girardi, Luisa Strocchio, Pietro Merli, Annelyse Garret Bernardin, Angela Galeotti, Fabio Magliarditi, Alessandro Inserra & Michele Callea. (2020) Oral Manifestations and Complications in Childhood Acute Myeloid Leukemia. Cancers 12:6, pages 1634.
Crossref
Pei-Pei Zhang, Yu-Chan Wang, Chun Cheng, Fei Zhang, Da-Zhi Ding & Da-Ke Chen. (2020) Runt-related transcription factor 2 influences cell adhesion-mediated drug resistance and cell proliferation in B-cell non-Hodgkin’s lymphoma and multiple myeloma. Leukemia Research 92, pages 106340.
Crossref
Ewa Hordyjewska‐Kowalczyk, Anna Sowińska‐Seidler, Ewelina M. Olech, Magdalena Socha, Renata Glazar, Anna Kruczek, Anna Latos‐Bieleńska, Przemko Tylzanowski & Aleksander Jamsheer. (2019) Functional analysis of novel RUNX2 mutations identified in patients with cleidocranial dysplasia . Clinical Genetics 96:5, pages 429-438.
Crossref
Cheng-Cao Sun, Shu-Jun Li, Zhen-Long Chen, Guang Li, Qian Zhang & De-Jia Li. (2019) Expression and Prognosis Analyses of Runt-Related Transcription Factor Family in Human Leukemia. Molecular Therapy - Oncolytics 12, pages 103-111.
Crossref
James C. Neil, Kathryn Gilroy, Gillian Borland, Jodie Hay, Anne Terry & Anna Kilbey. 2017. RUNX Proteins in Development and Cancer. RUNX Proteins in Development and Cancer 247 264 .
Daniel WysokinskiElzbieta PawlowskaJanusz Blasiak. (2015) RUNX2: A Master Bone Growth Regulator That May Be Involved in the DNA Damage Response. DNA and Cell Biology 34:5, pages 305-315.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.